Daily non-political popular news in brief.

New HIV vaccine target could solve mutation problem

While HERV are present in every cell, HIV may disrupt the normal constraints on HERV activity as it alters the cell to produce more HIV. A vaccine could be created containing HERV antigens that would stimulate T-cells targeting cells expressing HERV. Although the vaccine would not produce T-cells capable of recognizing HIV itself, it would evoke immune responses that could still protect people from becoming infected or limit the extent of damage caused by HIV.

Read more »

Keywords: hiv, vaccine, target, solve, mutation, problem

« Previous | Next »

Similar news on "New HIV vaccine target could solve mutation problem":

1. New target for HIV/AIDS drugs and vaccine discovered
   07-26-2007 · EurekAlert!
   Researchers from Rome, Italy, describe a finding in the August 2007 print issue of the FASEB Journal that could lead to new drugs to fight the HIV/AIDS virus, as well as new vaccines to prevent infection. In this report, researchers demonstrate for the first time how the HIV-1 Nef viral protein delivers a one-two punch to the body's innate immune system.
   Similar news · Read more »
   
2. New picture of HIV-1's protein jacket identifies target for antibody-based vaccine
   01-10-2008 · EurekAlert!
   By coaxing the HIV-1 protein to reveal a hidden portion of its protein coat, scientists at Dana-Farber Cancer Institute and Harvard Medical School have provided a newly detailed picture of how protective, or so-called broadly neutralizing, antibodies block HIV-1 infection. The discovery may provide scientists with an attractive target for antibody-based vaccine.
   Similar news · Read more »
   
3. Germany Sets Out To Develop Global HIV Cryobank
   10-06-2006 · ScienceDaily
   The HIV virus still poses unsolved problems. Despite decades of research, no vaccine yet exists. An international project supported by the Gates Foundation, Fraunhofer, and the Ministry of Economic Affairs of Saarland in Germany has set out to develop a global HIV cryobank.
   Similar news · Read more »
   
4. Vaccine hope for malaria
   05-23-2007 · EurekAlert!
   One person dies of it every 30 seconds, it rivals HIV and tuberculosis as the world's most deadly infection and the vast majority of its victims are under five years old. Now, just over 100 years since Britain’s Sir Ronald Ross was awarded the Nobel Prize for finally proving that malaria is transmitted by mosquitoes, researchers at The University of Nottingham believe they have made a significant breakthrough in the search for an effective vaccine.
   Similar news · Read more »
   
5. World AIDS Day: HIV prevention, diagnosis and treatment
   11-30-2007 · EurekAlert!
   On December 1, PLoS Medicine is publishing a collection of research articles and commentary, as well as an editorial to mark World AIDS Day 2007. In this release: Men who have sex with men face high AIDS risk in developing countries; Women disclose their HIV status at three key times around childbirth; Unnoticed mutation in AIDS virus can cause drug resistance; and HIV confirmatory test can also estimate recent infections.
   Similar news · Read more »
   
6. Overexcited neurons not good for cell health
   12-17-2007 · EurekAlert!
   A Northwestern University study reports that a mutation in a transcription factor that controls a neurotransmitter in the nematode C. elegans causes an imbalance in neuronal signaling that results in protein damage in target cells. Similar results and consequences on protein folding were found to occur upon exposure to the common toxins nicotine and lindane (a pesticide). Neurons become overexcited and fire incorrect signals too rapidly, resulting in proteins in target muscle cells becoming stressed, misfolding and becoming nonfunctional.
   Similar news · Read more »
   
7. Coated nanoparticles solve sticky drug-delivery problem
   01-24-2007 · EurekAlert!
   The layers of mucus that protect sensitive tissue throughout the body have an undesirable side effect: They can also keep helpful medications away. To overcome this hurdle, researchers have found a way to coat nanoparticles with a chemical that helps them slip through this sticky barrier.
   Similar news · Read more »
   
8. Virus used to create experimental HIV vaccines directly impairs the immune response
   11-15-2007 · EurekAlert!
   Leading efforts to create an HIV vaccine have hinged on the use of viruses as carriers for selected elements of the HIV virus. Recently, however, evidence has emerged that some of these so-called viral vector systems may undermine the immune system and should not be used for vaccine development. Now, a new study from scientists at the Wistar Institute provides strong support for the idea that some viral-vector vaccines may cause more harm than good.
   Similar news · Read more »
   
9. HIV isolate from Kenya provides clues for vaccine design
   01-02-2008 · EurekAlert!
   Two simple changes in its outer envelope protein could render the AIDS virus vulnerable to attack by the immune system, according to research from Kenya and the Fred Hutchinson Cancer Research Center published in PLoS Medicine.
   Similar news · Read more »
   
10. Immune cell communication key to hunting viruses, Jefferson immunologists show
    10-25-2006 · EurekAlert!
    Immunologists have used nanotechnology to create a novel "biosensor" to solve in part a perplexing problem in immunology: how the immune system's killer T-cells hunt down invading viruses. They have found that surprisingly little virus can turn on killer T-cells, thanks to some complicated communication among "antigen presenting" proteins that recognize and attach to the virus, making it visible to the immune system. Presenting proteins cooperate, spreading a signal among receptors and boosting T-cell response.
    Similar news · Read more »